Company / Total Assets
Pacira BioSciences, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3B
FY2025
5-year range
$1.3B / $2.1B
FY2021-FY2025
Trend
-18.6%
vs FY2024
Sector context
#66 of 214
Health Care
What the data says
At $1.3B, Pacira BioSciences, Inc.'s total assets ranks #66 of 214 in the Health Care sector. Total Assets has declined for 4 consecutive years, from $2.1B in FY2021 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of -0.2%.
Declined from $1.6B to $1.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -9.0%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#66 of 214 in Health CareTop 31% of 214This company $1.3B Sector average $7.5B
▼
-83.1% below sector average
Key checks
Key Insights
- Pacira BioSciences, Inc.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2025, total assets decreased 18.6% year-over-year.
- Ranks #66 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | -18.6% |
| FY2024 | $1.6B | -1.3% |
| FY2023 | $1.6B | -6.4% |
| FY2022 | $1.7B | -19.0% |
| FY2021 | $2.1B | +62.8% |
| FY2020 | $1.3B | +53.4% |
| FY2019 | $831.1M | +20.6% |
| FY2018 | $689.4M | +9.7% |
| FY2017 | $628.4M | +60.5% |
| FY2016 | $391.5M | +1.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026